Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HOLX Hologic Inc
- Stocks
- Healthcare
- NASDAQ: HOLX
Price (delayed)
$66.85
Market cap
$14.9B
P/E Ratio
27.97
Dividend/share
N/A
EPS
$2.39
Enterprise value
$16B
Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn
Highlights
Hologic's net income has decreased by 25% QoQ but it has increased by 19% YoY
The EPS has declined by 25% since the previous quarter but it is up by 22% year-on-year
The stock's price to earnings (P/E) is 31% more than its 5-year quarterly average of 21.1 and 13% more than its last 4 quarters average of 24.4
Hologic's quick ratio has decreased by 23% YoY and by 12% QoQ
Key stats
What are the main financial stats of HOLX
Market
Valuations
Earnings
Shares outstanding
222.85M
Market cap
$14.9B
Enterprise value
$16B
Price to earnings (P/E)
27.97
Price to book (P/B)
3.25
Price to sales (P/S)
3.75
EV/EBIT
19.88
EV/EBITDA
14.52
EV/Sales
3.97
Revenue
$4.03B
Gross profit
$2.08B
Operating income
$696.8M
Net income
$556.7M
EBIT
$804.7M
EBITDA
$1.1B
Free cash flow
$985.5M
Per share
Balance sheet
Liquidity
EPS
$2.39
EPS diluted
$2.36
Free cash flow per share
$4.36
Book value per share
$20.58
Revenue per share
$17.83
TBVPS
$18.81
Total assets
$8.55B
Total liabilities
$3.93B
Debt
$2.53B
Equity
$4.62B
Working capital
$2.22B
Debt to equity
0.55
Current ratio
3.24
Quick ratio
2.29
Net debt/EBITDA
1
Margins
Efficiency
Dividend
EBITDA margin
27.4%
Gross margin
51.6%
Net margin
13.8%
Operating margin
17.3%
Return on assets
6.3%
Return on equity
11.4%
Return on invested capital
19.1%
Return on capital employed
10.7%
Return on sales
20%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HOLX stock price
How has the Hologic stock price performed over time
Intraday
1.52%
1 week
3.2%
1 month
2.63%
1 year
-11.77%
YTD
-7.27%
QTD
2.59%
Financial performance
How have Hologic's revenue and profit performed over time
Revenue
$4.03B
Gross profit
$2.08B
Operating income
$696.8M
Net income
$556.7M
Gross margin
51.6%
Net margin
13.8%
Hologic's operating income has increased by 29% YoY but it has decreased by 24% QoQ
The operating margin has grown by 26% YoY but it has contracted by 23% from the previous quarter
The company's net margin fell by 25% QoQ but it rose by 17% YoY
Hologic's net income has decreased by 25% QoQ but it has increased by 19% YoY
Price vs fundamentals
How does HOLX's price correlate with its fundamentals
Growth
What is Hologic's growth rate over time
Valuation
What is Hologic stock price valuation
P/E
27.97
P/B
3.25
P/S
3.75
EV/EBIT
19.88
EV/EBITDA
14.52
EV/Sales
3.97
The stock's price to earnings (P/E) is 31% more than its 5-year quarterly average of 21.1 and 13% more than its last 4 quarters average of 24.4
The EPS has declined by 25% since the previous quarter but it is up by 22% year-on-year
HOLX's price to book (P/B) is 20% lower than its 5-year quarterly average of 4.0 and 6% lower than its last 4 quarters average of 3.4
HOLX's equity is down by 4.7% year-on-year and by 3.2% since the previous quarter
HOLX's price to sales (P/S) is 12% lower than its last 4 quarters average of 4.2 and 8% lower than its 5-year quarterly average of 4.0
Efficiency
How efficient is Hologic business performance
The ROE has contracted by 25% from the previous quarter but it has grown by 20% YoY
Hologic's return on assets has decreased by 25% QoQ but it has increased by 21% YoY
HOLX's return on invested capital is down by 24% since the previous quarter but it is up by 15% year-on-year
The return on sales has declined by 23% since the previous quarter but it is up by 18% year-on-year
Dividends
What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HOLX.
Financial health
How did Hologic financials performed over time
The total assets is 118% higher than the total liabilities
Hologic's quick ratio has decreased by 23% YoY and by 12% QoQ
Hologic's current ratio has decreased by 18% YoY and by 7% from the previous quarter
The company's debt is 45% lower than its equity
HOLX's equity is down by 4.7% year-on-year and by 3.2% since the previous quarter
Hologic's debt to equity has increased by 3.8% from the previous quarter and by 3.8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.